Arixtra

Arixtra uses and dosage

Arixtra (Fondaparinux Sodium) is a prescription medicine used to treat serious blood clots in the legs and/or lungs. Fondaparinux Sodium is usually used Prophylaxis of deep vein thrombosis (DVT) or acute pulmonary embolism (PE) when administered in conjunction with warfarin. If untreated, blood clots can travel to the lungs, heart, or brain, causing serious (possibly fatal) breathing problems, heart attack, or stroke. Fondaparinux Sodium is also used to prevent blood clots after certain surgeries with an increased risk of blood clots (such as hip fracture, abdominal, knee/hip replacement). Fondaparinux Sodium is a drug similar to heparin that works by blocking certain natural substances in the blood that cause clotting. Arixtra is manufactured by ASPEN Pharma Ltd. in FRANCE. Fondaparinux Sodium is given by injection into a vein by a health care professional. Patient`s doctor will choose

Arixtra side effects

The most common adverse reactions of Fondaparinux Sodium are: Pain, bruising, redness, and swelling at the injection site.

Originator brand

Arixtra by MYLAN IRELAND

Made by

ASPEN Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.